Page 12 - SLIDES
P. 12

653O: Pembrolizumab vs placebo as adjuvant therapy



                                           for patients with renal cell carcinoma




                                 Patient-reported outcomes in KEYNOTE-564
   7   8   9   10   11   12   13   14   15   16   17